Early Quality of Life in Patients with Localized Prostate Carcinoma: an Examination of Treatment-related, Demographic, and Psychosocial Factors

Overview

Journal Cancer

Publisher Wiley

Specialty Oncology

Date 2001 Dec 18

PMID 11745222

Citations 56

Authors

D T Eton

S J Lepore

V S Helgeson

Affiliations

Soon will be listed here.

Abstract

Background: Men with localized prostate carcinoma are faced with important treatment decisions, and quality of life (QoL) information has become a crucial element of decision making. The first objective of this study was to compare the early, health-related QoL (HRQoL) of men with localized prostate carcinoma who were treated with radical prostatectomy, external beam radiotherapy, or brachytherapy. A second objective was to identify demographic and psychosocial variables that predict HRQoL.

Methods: Two-hundred fifty-six men with localized prostate carcinoma were interviewed within 7 weeks of treatment initiation. The interview included measures of prostate-specific HRQoL (the University of California-Los Angeles Prostate Cancer Index), general HRQoL (the SF-36), and psychosocial variables.

Results: After adjusting for covariates, treatment group differences were found for both prostate specific HRQoL and general HRQoL. Men who underwent prostatectomy reported more urinary and sexual problems and more general physical dysfunction compared with men who were treated with either form of radiation therapy. Men who were treated with brachytherapy reported the fewest problems in sexual function and the least general physical dysfunction. Few treatment group differences were found in mental functioning. Both demographic factors and psychosocial factors predicted HRQoL. Older men and African-American men reported more physical problems than younger men and Caucasian men, respectively. A supportive social environment, high self-efficacy, and high self-esteem were predictive of better HRQoL.

Conclusions: Shortly after undergoing treatment for localized prostate carcinoma, men who underwent radical prostatectomy, older men, and African-American men are at heightened risk for experiencing prostate-specific and general deficits in HRQoL. Having psychosocial resources from which to draw may enhance HRQoL.

Citing Articles

Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US.

Rencsok E, Slopen N, Autio K, Morgans A, McSwain L, Barata P Qual Life Res. 2023; 32(11):3209-3221.

PMID: 37410340 PMC: 10711502. DOI: 10.1007/s11136-023-03468-0.

The impact of socioeconomic status on the survival of men with early-onset prostate cancer.

Riveros C, Al-Toubat M, Chalfant V, ElShafei A, Feibus A, Forero A Am J Clin Exp Urol. 2023; 11(2):146-154.

PMID: 37168939 PMC: 10165226.

Five-year follow-up study of a population-based prospective cohort of men with low-risk prostate cancer: the treatment options in prostate cancer study (TOPCS): study protocol.

Xu J, Goodman M, Janisse J, Cher M, Bock C BMJ Open. 2022; 12(2):e056675.

PMID: 35190441 PMC: 8860062. DOI: 10.1136/bmjopen-2021-056675.

Social constraints and cancer-related quality of life in single and partnered young adult testicular cancer survivors: a contextual approach.

Llave K, Hoyt M J Psychosoc Oncol. 2022; 40(6):743-755.

PMID: 35068347 PMC: 9308827. DOI: 10.1080/07347332.2021.2002995.

Quality of life and adjustment in men with prostate cancer: Interplay of stress, threat and resilience.

Groarke A, Curtis R, Skelton J, Groarke J PLoS One. 2020; 15(9):e0239469.

PMID: 32941547 PMC: 7498057. DOI: 10.1371/journal.pone.0239469.

References

Stewart A, Hays R, Ware Jr J . The MOS short-form general health survey. Reliability and validity in a patient population. Med Care. 1988; 26(7):724-35. DOI: 10.1097/00005650-198807000-00007. View

Brandeis J, Litwin M, Burnison C, Reiter R . Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol. 2000; 163(3):851-7. View

Stanford J, Feng Z, Hamilton A, Gilliland F, Stephenson R, Eley J . Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA. 2000; 283(3):354-60. DOI: 10.1001/jama.283.3.354. View

Lim A, Brandon A, Fiedler J, Brickman A, Boyer C, Raub Jr W . Quality of life: radical prostatectomy versus radiation therapy for prostate cancer. J Urol. 1995; 154(4):1420-5. DOI: 10.1016/s0022-5347(01)66881-2. View

Litwin M, Flanders S, Pasta D, Stoddard M, Lubeck D, Henning J . Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 1999; 54(3):503-8. DOI: 10.1016/s0090-4295(99)00172-7. View

Katz J, Chang L, Sangha O, Fossel A, Bates D . Can comorbidity be measured by questionnaire rather than medical record review?. Med Care. 1996; 34(1):73-84. DOI: 10.1097/00005650-199601000-00006. View

Fowler Jr F, Barry M, Lu-Yao G, Wasson J, Bin L . Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol. 1996; 14(8):2258-65. DOI: 10.1200/JCO.1996.14.8.2258. View

Lu-Yao G, Yao S . Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet. 1997; 349(9056):906-10. DOI: 10.1016/S0140-6736(96)09380-4. View

Kjellberg J, McPherson C, Murray C . Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer. 1997; 79(10):1977-86. DOI: 10.1002/(sici)1097-0142(19970515)79:10<1977::aid-cncr20>3.0.co;2-r. View

10.

Lubeck D, Litwin M, Henning J, Stoddard M, Flanders S, Carroll P . Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. Urology. 1999; 53(1):180-6. DOI: 10.1016/s0090-4295(98)00408-7. View

11.

Litwin M, McGuigan K, Shpall A, Dhanani N . Recovery of health related quality of life in the year after radical prostatectomy: early experience. J Urol. 1999; 161(2):515-9. View

12.

Zelefsky M, Wallner K, Ling C, Raben A, Hollister T, Wolfe T . Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol. 1999; 17(2):517-22. DOI: 10.1200/JCO.1999.17.2.517. View

13.

Lilleby W, Fossa S, Waehre H, Olsen D . Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys. 1999; 43(4):735-43. DOI: 10.1016/s0360-3016(98)00475-1. View

14.

Helgeson V, Cohen S, Schulz R, Yasko J . Education and peer discussion group interventions and adjustment to breast cancer. Arch Gen Psychiatry. 1999; 56(4):340-7. DOI: 10.1001/archpsyc.56.4.340. View

15.

Robinson L, Hughes L, Adler D, Strumpf N, Grobe S, McCorkle R . Describing the work of nursing: the case of postsurgical nursing interventions for men with prostate cancer. Res Nurs Health. 1999; 22(4):321-8. DOI: 10.1002/(sici)1098-240x(199908)22:4<321::aid-nur6>3.0.co;2-x. View

16.

Litwin M, Hays R, Fink A, Ganz P, Leake B, Leach G . Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995; 273(2):129-35. DOI: 10.1001/jama.273.2.129. View

17.

Chodak G, Thisted R, Gerber G, Johansson J, Adolfsson J, Jones G . Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994; 330(4):242-8. DOI: 10.1056/NEJM199401273300403. View

18.

Hanks G . Radiotherapy or surgery for prostate cancer? Ten and fifteen-year results of external beam therapy. Acta Oncol. 1991; 30(2):231-7. DOI: 10.3109/02841869109092359. View